Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility

Frontiers in Psychiatry
Koby CohenAviv Weinstein

Abstract

We have recently shown that chronic use of Synthetic Cannabinoids (SCs) has been associated with mood disorders and impairments in executive functions. There is also evidence indicating that chronic SC users have higher rates of comorbidity with depression and psychotic symptoms. Here, we investigate performance on executive function and emotional processing tasks in regular SC users and a measure of schizotypal traits. Thirty chronic SC users, 32 recreational cannabis users, and 32 non-using control participants, without history of mental disorder, or current substance abuse diagnosis (mean age 26 ± 4.27 years; 85 males, 9 females), were tested in addiction treatment centers in Israel. Computerized neurocognitive function tests; the N-back task, Go/No-Go task, Wisconsin Sorting Card-like Task (WSCT), and emotional face recognition task and questionnaires of depression, anxiety and schizotypal traits and symptoms were used. SC users have performed worse than recreational cannabis users and non-cannabis users on the N-back working-memory task (lower accuracy) and the WSCT cognitive flexibility task. SC users showed greater schizotypal traits and symptoms compared with recreational cannabis users and non-user control participants...Continue Reading

References

Nov 1, 2001·Archives of General Psychiatry·H G PopeD Yurgelun-Todd
Feb 19, 2002·Psychiatry Research·Patrick DumasThierry d'Amato
Jun 25, 2002·European Journal of Pharmacology·Nobuaki EgashiraMichihiro Fujiwara
Mar 31, 2004·European Psychiatry : the Journal of the Association of European Psychiatrists·Elizabeth L Bailey, Brian L Swallow
Jun 3, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak Cyril D'SouzaJohn Harrison Krystal
Mar 17, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yoshinobu KawamuraMasanobu Kano
Apr 1, 2006·Neuroscience and Biobehavioral Reviews·Alice EgertonJudith A Pratt
Oct 26, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Francis Rodriguez BambicoGabriella Gobbi
Apr 22, 2008·European Journal of Pharmacology·Tommy PattijAnton N M Schoffelmeer
Mar 17, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Fabrício A MoreiraBeat Lutz
Jul 18, 2009·European Archives of Psychiatry and Clinical Neuroscience·Deepak Cyril D'SouzaMohini Ranganathan
Aug 7, 2009·Drug and Alcohol Dependence·Staci A GruberDeborah A Yurgelun-Todd
Sep 22, 2009·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·K M MillerD Bowers
Dec 19, 2009·Psychological Medicine·K E Scholes, M T Martin-Iverson
Apr 22, 2010·Memory·Susanne M JaeggiBeat Meier
Sep 21, 2010·Journal of Psychopharmacology·Emma BarkusRobin M Murray
Jan 22, 2011·Annals of Emergency Medicine·Joshua R SimmonsBrandon K Wills
Jun 15, 2011·Psychiatry Research·Eduardo Fonseca-PedreroJosé Muñiz
Sep 24, 2011·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Daniel CastellanosAna Moreno
Sep 29, 2011·Frontiers in Behavioral Neuroscience·Claudio ZanettiniSevil Yasar
Oct 19, 2011·Frontiers in Behavioral Neuroscience·Liana Fattore, Walter Fratta
Mar 16, 2012·Journal of Psychiatric Practice·Daniel Castellanos, Gabriel Thornton
Apr 12, 2012·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Vikhyat S BebartaShawn M Varney
May 9, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kathryn A SeelyLiana Fattore
May 16, 2012·Journal of Psychopharmacology·Michael E BallardHarriet de Wit
Oct 2, 2012·Annual Review of Psychology·Adele Diamond
Jul 9, 2013·Current Pharmaceutical Design·Matthijs G BossongPaul Allen
Jul 10, 2013·Psychopharmacology·Max SpadernaDeepak Cyril D'Souza
Aug 10, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Matthijs G BossongJ Martijn Jansma

❮ Previous
Next ❯

Citations

Sep 26, 2020·The European Journal of Neuroscience·Tibor M Brunt, Matthijs G Bossong

❮ Previous
Next ❯

Software Mentioned

Statistical Package for Social Science ( SPSS )

Related Concepts

Related Feeds

Cannabis & Cognition

The effect of cannabis on cognitive functioning is being explored for short and long-term effects. Recent studies have shown conflicting results, with some showing no significant effects and others showing neuropsychological impairment. Discover the latest research on cannabis and cognition here.

© 2021 Meta ULC. All rights reserved